Enveric Biosciences Inc stock is traded at $1.40, with a volume of 3,362. It is up 0.00% in the last 24 hours and down -4.76% over the past month. Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Previous Close:
$1.40
Open:
$1.39
24h Volume:
3,362
Relative Volume:
0.10
Market Cap:
$6.27M
Revenue:
$35.41M
Net Income/Loss:
-$8.22M
P/E Ratio:
-
EPS:
-$27.35
Net Cash Flow:
-$8.01M
1W Performance:
-2.10%
1M Performance:
-4.76%
6M Performance:
-55.97%
1Y Performance:
-76.82%
1-Day Range:
$1.39$1.46
1-Week Range:
$1.37$1.58
52-Week Range:
$1.17$13.25
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences IncSector
HealthcareIndustry
BiotechnologyPhone
(617) 444-8400Address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS